Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
3.
Cancer Chemother Pharmacol ; 10(3): 192-3, 1983.
Article in English | MEDLINE | ID: mdl-6861264

ABSTRACT

Cyclophosphamide was given as IV doses of 50 mg/kg/day on each of four successive days as treatment for ovarian and lung cancer. Blood samples were taken at regular intervals and analysed for cyclophosphamide by gas liquid chromatography. The plasma half-lives (t 1/2) and volumes of distribution (V D) were calculated for each of the treatment days; t 1/2 was found to decrease with subsequent doses whereas V D was not significantly changed.


Subject(s)
Cyclophosphamide/blood , Lung Neoplasms/blood , Ovarian Neoplasms/blood , Cyclophosphamide/administration & dosage , Dose-Response Relationship, Drug , Female , Half-Life , Humans , Kinetics , Lung Neoplasms/drug therapy , Male , Ovarian Neoplasms/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...